Back to company

PHARMPROTECH HOLDING ApS: Financial statements 2023

CVR: 29174644

PHARMPROTECH HOLDING ApS (CVR 29174644) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -17,100 and a net result of DKK 5,189,592 compared with DKK 5,580,991 the year before. Equity amounted to DKK 28,779,019. The solvency ratio was 83%.

Gross Profit
-17,100 kr.
Profit/Loss
5,189,592 kr.
Equity
28,779,019 kr.
Total Assets
34,680,162 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023--17 t.5.2 mio.28.8 mio.-
2022--10 t.5.6 mio.23.6 mio.-
2021--10 t.1.3 mio.18.1 mio.-
2020--6 t.5.4 mio.16.8 mio.-
2019--44 t.1.9 mio.11.6 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

About PHARMPROTECH HOLDING ApS

PHARMPROTECH HOLDING ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2005. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Tony Christensen. The company is owned by Tony Christensen. In 2025, the company reported a gross profit of DKK -767,188 and a net result of DKK 3,595,179 compared with DKK 5,877,922 the year before. Equity amounted to DKK 38,132,221.